News Lava fires up a $700m cancer licensing deal with Seagen While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting
News AZ, Ionis hit by unexpected Wainua trial failure Prospects for AstraZeneca and Ionis' Wainua have been severely dented by a failed trial in ATTR cardiomyopathy, weighing on the shares of both firms.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
